Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-21
2000-02-15
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3141
Patent
active
060253770
ABSTRACT:
A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals that comprises a material is disclosed. The particular material used is a 1H-1,2,4-triazole derivative. These compounds can also be used to treat viral infections.
REFERENCES:
patent: 4079062 (1978-03-01), Van Reet et al.
patent: 4160838 (1979-07-01), Van Reet et al.
patent: 4404216 (1983-09-01), Richardson
patent: 4490540 (1984-12-01), Heeres
patent: 5114951 (1992-05-01), King
patent: 5126359 (1992-06-01), Stroech et al.
patent: 5211736 (1993-05-01), Lai
patent: 5360612 (1994-11-01), Fries et al.
patent: 5565478 (1996-10-01), Kohn et al.
patent: 5665751 (1997-09-01), Camden
Physicians Desk Reference, 15:35:33, Diflucan, Medical Economics Data Pro. Co., Montvale,NJ, 1995.
Benzaquen et al., Nature Medicine, 1, (6), Jun. 1995.
Schwartz et al., Biochem Pharmacol., vol. 50, No. 7, pp. 923-928, Sep. 1995 .
Dabek Rose Ann
Goldberg Jerome D.
Rasser Jacobus C.
The Procter & Gamble & Company
LandOfFree
Pharmaceutical composition for inhibiting the growth of cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for inhibiting the growth of cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for inhibiting the growth of cancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1906241